DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6+ months with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Patients may be appropriate for DUPIXENT if they1: